Show simple item record

dc.contributor.authorXing, Den
dc.contributor.authorCorbel, M. Jen
dc.contributor.authorNewland, Pen
dc.contributor.authorWorld Health Organization. Biologicals Uniten
dc.contributor.authorWHO Expert Committee on Biological Standardization (‎2004 : Geneva, Switzerland)‎en
dc.date.accessioned2012-06-17T01:32:46Z
dc.date.available2012-06-17T01:32:46Z
dc.date.created2004en
dc.date.issued2004en
dc.identifier.govdocWHO/BS/04.1998en
dc.identifier.urihttp://www.who.int/iris/handle/10665/69928
dc.descriptionPresented at the meeting of the Expert Committee on Biological Standardization, Geneva, 15 to 19 November 2004en
dc.descriptionWHO/BS/04.1998en
dc.description38 p.en
dc.language.isoenen
dc.publisherGeneva : World Health Organizationen
dc.subject.meshAntibodies, Monoclonalen
dc.subject.meshBordetella pertussisen
dc.subject.meshIndicators and reagentsen
dc.subject.meshReference standardsen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleEvaluation of purified monoclonal antibodies to Bordetella pertussis fimbriae type 2 and 3 : study report and proposal to establish WHO reference reagents / D. Xing ... [‎et al]‎en
dc.subject.meshqualifieranalysisen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record